InnovAge Reports 15.9% Revenue Growth to $989.7 Million for Fiscal Year Ending June 30, 2026

InnovAge Holding Corp. reported significant financial growth for the fiscal year ending June 30, 2026, with total revenues reaching $989.7 million, a 15.9% increase from $853.7 million in the previous year. The rise in revenue was primarily driven by a 16.0% increase in capitation revenue, which amounted to $988.4 million, attributed to a 7.8% increase in member months and a 7.6% rise in capitation rates. The company served approximately 8,230 participants, maintaining its position as the largest PACE provider in the United States.

Despite the revenue growth, InnovAge faced rising operational costs, with total expenses increasing by 11.7% to $987.1 million. Notably, external provider costs rose by 4.3% to $449.8 million, while the cost of care, excluding depreciation and amortization, surged by 16.1% to $312.1 million. Corporate, general, and administrative expenses also saw a significant increase of 36.4%, totaling $166.5 million, largely due to higher employee compensation and litigation costs. The company reported an operating income of $2.6 million, a notable recovery from an operating loss of $29.8 million in the prior year.

Strategically, InnovAge has focused on expanding its footprint, operating 20 PACE centers across six states, including California, Colorado, Florida, New Mexico, Pennsylvania, and Virginia. The company has also initiated the conversion of two legacy PACE centers to alternate care settings in Pennsylvania to enhance operational efficiency. Additionally, InnovAge has pursued joint ventures, such as those with Orlando Health and Tampa General Hospital, to bolster its service offerings and community outreach.

Looking ahead, InnovAge anticipates challenges related to increased costs of care and regulatory pressures, particularly from the Reconciliation Act, which may impact Medicaid funding and eligibility. The company is also navigating a labor market characterized by shortages and rising wage pressures, which could affect its ability to recruit and retain staff. Despite these challenges, InnovAge remains committed to its growth strategy, focusing on increasing participant enrollment and optimizing its care delivery model to improve health outcomes for its participants.

In terms of financial outlook, InnovAge's management expressed confidence in its ability to manage costs and maintain operational efficiency, although they acknowledged the potential for increased expenses in the coming fiscal year. The company continues to monitor the evolving regulatory landscape and its implications for future operations, emphasizing the importance of compliance and quality care in its business model.